Create a Free Account
or
Create a Free Account
or
| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Arcadia Biosciences (NASDAQ:RKDA) with a Buy and maintains $6 ...
Arcadia Biosciences (NASDAQ:RKDA) reported quarterly earnings of $0.78 per share which missed the analyst consensus estimate of...
- SEC Filing
HC Wainwright & Co. analyst Raghuram Selvaraju maintains Arcadia Biosciences (NASDAQ:RKDA) with a Buy and lowers the pri...
Arcadia Biosciences, Inc.® (NASDAQ:RKDA), a producer and m
-- Company advances monetization of wheat technology with one-time payment of $4 million --Arcadia Biosciences, Inc.® (NASDAQ:R...
Arcadia Biosciences (NASDAQ:RKDA) reported quarterly losses of $(1.78) per share which beat the analyst consensus estimate of $...
HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Arcadia Biosciences (NASDAQ:RKDA) with a Buy and maintains $10...
